Drug intelligence / Profile preview

pentamidine

Development stage
Approved
Lead developer
Astellas Pharma
Modality
Small Molecules
Administration
Intravenous, Intramuscular, Inhalation
01

Overview

Pentamidine is an antimicrobial and antiprotozoal small molecule used primarily to treat and prevent Pneumocystis pneumonia (PCP), especially in immunocompromised patients such as those with HIV/AIDS. It is also effective against other protozoal infections including African trypanosomiasis (sleeping sickness), leishmaniasis, babesiosis, and Balamuthia infections. The precise mechanism of action is not fully understood but involves interference with nuclear metabolism in susceptible organisms—specifically inhibiting the synthesis of DNA, RNA, phospholipids, and proteins. Pentamidine can be administered via inhalation or injection[1][2][3][6].

Brand names
NebupentPentamPentam 300Pentam300Pentam-300
Other names
pentamidinumpentamidinapentamidin1,5-bis(4-amidinophenoxy)pentane4,4'-(1,5-pentanediylbis(oxy))bis-benzenecarboximidamide4,4'-(pentamethylenedioxy)dibenzamidinep,p'-(pentamethylenedioxy)dibenzamidine
02

Targets

AMD1 (S-adenosylmethionine decarboxylase)MicrotubulekDNA (Kinetoplast DNA)

Beyond the preview

Go deeper on pentamidine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pentamidine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call